Therefore, it is reasonable to speculate that BEX1, G6PC and GCLM can be used as potential therapeutic targets of HCC to mediate the mechanism of cuproptosis in hepatocytes. This evidence concerns the gene BEX1 and hepatocellular carcinoma.